The P53 pathway can be inactivated through elevated expression of several lncRNAs, which has been demonstrated for Antisense Non-coding RNA In the INK4 Locus (ANRIL) in prostate cancer [336]. This evidence concerns the gene CDKN2A and prostate carcinoma.